Symbols

How did OBIO's revenue and expenses trend in Q4 2024?

4/14/2025 05:43am

Aime

Orchestra BioMed (OBIO) experienced a revenue of $633,000 in Q4 2024, with total expenses amounting to $16.87 million, comprising $10.97 million in R&D expenses and $5.9 million in selling, general, and administrative (SG&A) expenses¹.

1/2

OBIO Revenue By Business

Source:

1. OBIO Revenue by Business, R&D Expenses, Sales and Marketing Expenses, General and Administrative Expenses in Q4 2024